Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

768 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
Fenwick E, O'Brien BJ, Briggs A. Fenwick E, et al. Among authors: briggs a. Health Econ. 2004 May;13(5):405-15. doi: 10.1002/hec.903. Health Econ. 2004. PMID: 15127421
Within this paper we present a 'gallery' of CEACs in order to identify the fallacies and illustrate the facts surrounding the CEAC. The aim of the paper is to serve as a reference tool to accompany the increased use of CEACs within major medical journals....
Within this paper we present a 'gallery' of CEACs in order to identify the fallacies and illustrate the facts surrounding the CEAC. T …
Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences.
Crott R, Briggs A. Crott R, et al. Among authors: briggs a. Eur J Health Econ. 2010 Aug;11(4):427-34. doi: 10.1007/s10198-010-0233-7. Epub 2010 May 16. Eur J Health Econ. 2010. PMID: 20473703
OBJECTIVE: To develop a mapping algorithm to transform the EORTC QLQ-C30 questionnaire responses into EQ-5D derived utilities. STUDY DESIGN: Retrospective data analysis of a multicentre, multicountry prospective clinical trial in breast cancer patients. ...
OBJECTIVE: To develop a mapping algorithm to transform the EORTC QLQ-C30 questionnaire responses into EQ-5D derived utilities. STUDY …
EQ-5D-5L: Smaller steps but a major step change?
Brazier J, Briggs A, Bryan S. Brazier J, et al. Among authors: briggs a. Health Econ. 2018 Jan;27(1):4-6. doi: 10.1002/hec.3627. Health Econ. 2018. PMID: 29411469 No abstract available.
Editorial.
Briggs A, Nugent R. Briggs A, et al. Health Econ. 2016 Feb;25 Suppl 1(Suppl Suppl 1):6-8. doi: 10.1002/hec.3321. Health Econ. 2016. PMID: 26804358 Free PMC article. No abstract available.
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
McMurray JJV, Trueman D, Hancock E, Cowie MR, Briggs A, Taylor M, Mumby-Croft J, Woodcock F, Lacey M, Haroun R, Deschaseaux C. McMurray JJV, et al. Among authors: briggs a. Heart. 2018 Jun;104(12):1006-1013. doi: 10.1136/heartjnl-2016-310661. Epub 2017 Dec 21. Heart. 2018. PMID: 29269379 Free PMC article.
OBJECTIVE: Chronic heart failure with reduced ejection fraction (HF-REF) represents a major public health issue and is associated with considerable morbidity and mortality. ...METHODS: A cost-utility analysis was performed based on data from a multinational, …
OBJECTIVE: Chronic heart failure with reduced ejection fraction (HF-REF) represents a major public health issue and is associated wit …
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.
Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Deckers J, Ferrari R, Remme WJ, Bertrand M, Fox K; EUROPA Trial Investigators. Briggs A, et al. Heart. 2007 Sep;93(9):1081-6. doi: 10.1136/hrt.2005.086728. Epub 2006 Nov 29. Heart. 2007. PMID: 17135223 Free PMC article. Clinical Trial.
A cost-effectiveness analysis is presented as a function of the risk of a primary event (non-fatal myocardial infarction, cardiac arrest or cardiovascular death) in order to identify people for whom treatment offers greatest value for money. ...For a t
A cost-effectiveness analysis is presented as a function of the risk of a primary event (non-fatal myocardial infarctio
Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care.
Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A, Briggs A, Hobbs FD. Delaney BC, et al. Among authors: briggs a. Lancet. 2000 Dec 9;356(9246):1965-9. doi: 10.1016/s0140-6736(00)03308-0. Lancet. 2000. PMID: 11130524 Clinical Trial.
Initial endoscopy resulted in a significant improvement in symptom score (p=0.03), and quality of life pain dimension (p=0.03), and a 48% reduction in the use of proton pump inhibitors (p=0.005). ...INTERPRETATION: Initial endoscopy in dyspeptic patients over age 50 …
Initial endoscopy resulted in a significant improvement in symptom score (p=0.03), and quality of life pain dimension (p=0.03), and …
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M. Williams C, et al. Among authors: briggs a. Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170 Review.
The data were used to estimate directly a parametric regression-based risk equation, from which a prognostic index was developed, and prognosis-specific estimates of the baseline breast cancer hazard could be observed. ...A risk table format enabling clinicia …
The data were used to estimate directly a parametric regression-based risk equation, from which a prognostic index was develop …
Centre-specific or average unit costs in multi-centre studies? Some theory and simulation.
Raikou M, Briggs A, Gray A, McGuire A. Raikou M, et al. Among authors: briggs a. Health Econ. 2000 Apr;9(3):191-8. doi: 10.1002/(sici)1099-1050(200004)9:3<191::aid-hec510>3.0.co;2-1. Health Econ. 2000. PMID: 10790698
Using a pre-specified production relation between the different volumes of resource use, and simulating changes in unit costs, it is shown that these two methods result in statistically different estimates of average treatment costs. ...The findings suggest that a m …
Using a pre-specified production relation between the different volumes of resource use, and simulating changes in unit costs, it is …
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.
Briggs A, Sculpher M, Buxton M. Briggs A, et al. Health Econ. 1994 Mar-Apr;3(2):95-104. doi: 10.1002/hec.4730030206. Health Econ. 1994. PMID: 8044216 Review.
With the increased use of the clinical trial as a vehicle for economic evaluation, there has been recent interest in how the statistical methods routinely employed to handle uncertainty in clinical research might be applied to economic evaluation. ...Sensitivity analysis i …
With the increased use of the clinical trial as a vehicle for economic evaluation, there has been recent interest in how the statisti …
768 results
Jump to page
Feedback